BackNovoCure Overview

NovoCure Cost of Revenue

Cost of Revenue analysis for NVCR.

Quarterly Cost of Revenue

$38.93M
1.06% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$167.29M
17.8% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)